These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 6407770)

  • 1. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE; Tsou E; Smith FP; Kerwin DM
    Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 3. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma.
    Kressel BR; Ryan KP; Duong AT; Berenberg J; Schein PS
    Cancer; 1981 Oct; 48(8):1738-45. PubMed ID: 7284973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature.
    Rabadi SJ; Khandekar JD; Miller HJ
    Cancer Treat Rep; 1982 May; 66(5):1244-7. PubMed ID: 7083229
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD; Wiley EL; Abeloff MD
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapeutic agents and the erythron.
    Doll DC; Weiss RB
    Cancer Treat Rev; 1983 Sep; 10(3):185-200. PubMed ID: 6413059
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic anemia associated with antineoplastic agents.
    Doll DC; Weiss RB
    Cancer Treat Rep; 1985; 69(7-8):777-82. PubMed ID: 3160460
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.